Familial hypercholesterolemia (FH) is a common genetic disorder leading to high cholesterol levels from birth and increased risk of atherosclerotic cardiovascular disease. Heterozygous FH occurs in approximately 1 in 250 people in many populations. Homozygous FH can lead to coronary artery disease in childhood and adolescence. Early treatment can decrease the risk of premature atherosclerotic cardiovascular disease in FH